Cipla Ltd (CIPLA) β Board Meeting | 28 September 2026
Cipla announced a board meeting on October 27, 2026, to approve unaudited financial results for the quarter and half year ended September 30, 2026, with trading restrictions on its shares from October 1 to October 29, 2026, as per SEBI regulations.
About Cipla Ltd (CIPLA)
Healthcare Β· Pharmaceuticals Β· Listed on BSE
π‘ Get AI alerts when CIPLA files next
Free β’ Daily 5 PM digest β’ Track filings, board meetings, and corporate actions
Track CIPLA β Freeπ‘ Ask AI about this filing
π More CIPLA filings
- π΄ Corporate Action β 24 September 2026Cipla announced the allotment of 12,168 fully paid-up equity shares of INR 2 each under its ESOS 201...
- π΄ Announcement β 22 September 2026Cipla announced that Global Head Supply Chain Venkata Sai Mungara will transition to Chief of Manufa...
- π΄ Announcement β 18 September 2026Cipla announced it received an ESG rating of 68 from Niche, a SEBI-registered provider, communicated...
- π΄ Announcement β 3 September 2026Cipla announced an exclusive partnership with Qilu Pharmaceutical to license and supply a biosimilar...
- π΄ Announcement β 3 September 2026Cipla announced that following an NCLT order dated 18 August 2026, it is sending notices to sharehol...
π₯ Also filed on 28 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only β not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
π‘ Get AI alerts when CIPLA files new disclosures
Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CIPLA β FreeFree account Β· 2 AI queries/day